Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 wt » _ wt (Expand Search), i wt (Expand Search), 2 w (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 wt » _ wt (Expand Search), i wt (Expand Search), 2 w (Expand Search)
-
98181
Table_1_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX
Published 2023“…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”
-
98182
Supplementary Material for: Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable He...
Published 2022“…Cases without decreased blood flow in TIC analysis (<i>n</i> = 10) had more cases with PD compared with cases with decreased blood flow (60 vs. 0%, <i>p</i> = 0.001). …”
-
98183
Table_1_Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.docx
Published 2024“…GNAQ and GNA11 mutations were common in uveal melanomas, while MAP-Kinase mutations were frequent in non-uveal melanomas with NF1, BRAF V600 and NRAS Q61 mutations occurring in decreasing frequency, consistent with a strong UV association. …”
-
98184
Data_Sheet_1_Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung...
Published 2022“…When compared with lorlatinib and alectinib, ensartinib was associated with a lower QALY and decreased total costs; the ICERs for lorlatinib and alectinib were $934,101/ QALY and $164,888/ QALY, respectively.…”
-
98185
-
98186
-
98187
-
98188
-
98189
-
98190
-
98191
-
98192
-
98193
-
98194
-
98195
-
98196
-
98197
-
98198
-
98199
-
98200